<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/451"/><api:result><api:object category="publication" id="451" last-affected-when="2024-03-14T05:32:31.43+00:00" last-modified-when="2024-03-14T05:32:31.43+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/451" created-when="2010-05-17T13:46:20.36+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-04-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1518153" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1016/S0954-6111(99)90021-5" last-modified-when="2022-09-11T06:50:47.23+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kuss</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Berrisoul</api:last-name><api:initials>F</api:initials><api:first-names>F</api:first-names><api:separate-first-names><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kearsley</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Torres</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kubin</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0954-6111(99)90021-5</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0954-6111(99)90021-5"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0954-6111(99)90021-5"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6111</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Respiratory Medicine</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>252</api:begin-page><api:end-page>261</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier BV</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1016/s0954-6111(99)90021-5</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>2</api:day><api:month>4</api:month><api:year>2020</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>93</api:text></api:field></api:native></api:record><api:record format="native" id="451" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10464889" last-modified-when="2020-04-29T00:32:47.46+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A multinational, multicentre, randomized, prospective, parallel-group study compared treatment with ciprofloxacin administered as an oral suspension (500 mg twice daily for 7 days) with co-amoxiclav tablets (625 mg three times daily for 7 days) in patients suffering from acute exacerbations of chronic bronchitis (AECB). A total of 147 of 165 cases treated with ciprofloxacin (89.1%) and 146 of 162 cases treated with co-amoxiclav (90.1%) were classified as being clinical successes at the primary efficacy assessment 7 days after the end of therapy (assessed as reduced cough, improvement in dyspnoea, reduction in 24-h sputum volume or reduced purulence of sputum). Treatment equivalence was statistically confirmed; treatment difference:--1.0%, 95% CI--6.6% and 4.5%. Before treatment, 128 bacterial strains were isolated from 103 patients (60 ciprofloxacin and 68 co-amoxiclav). The most commonly isolated organism was Haemophilus influenzae (60 isolates), followed by Moraxella catarrhalis (12 isolates), Streptococcus pneumoniae (11 isolates) and Staphylococcus aureus (10 isolates). At day 14, 40 of 46 ciprofloxacin-treated patients (87.0%) and 46 of 55 co-amoxiclav-treated patients (83.6%) who were valid for bacteriological analysis were classified as being bacteriological success (classed as eradication, eradication with colonization or presumed eradication; treatment difference: 3.3%, 95% CI--8.3% and 14.9%). The adverse event profile was comparable between treatment groups. Most adverse events considered possibly or probably related to study drug were related to the gastrointestinal system and were of mild or moderate severity: nausea (13% ciprofloxacin, 10.6% co-amoxiclav), flatulence (10.3% ciprofloxacin, 3.9% co-amoxiclav), abdominal pain (7.6% ciprofloxacin, 7.3% co-amoxiclav) and diarrhoea (4.3% ciprofloxacin, 6.7% co-amoxiclav). We concluded that a 7-day course of ciprofloxacin suspension is equivalent to a 7-day course of co-amoxiclav tablets in terms of clinical and bacteriological efficacy and tolerability for the treatment of AECB. Thus, ciprofloxacin suspension may offer a suitable alternative treatment for AECB patients who have difficulty in swallowing, or who prefer liquid medications to tablets.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Royal Hallamshire Hospital, Sheffield, U.K.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Kuss</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Berrisoul</api:last-name><api:initials>F</api:initials><api:first-names>F</api:first-names><api:separate-first-names><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kearsley</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Torres</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kubin</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10464889</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0954-6111(99)90021-5</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0954-6111(99)90021-5"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0954-6111(99)90021-5"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6111</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Respir Med</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Acute Disease</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Amoxicillin-Potassium Clavulanate Combination</api:keyword><api:keyword scheme="mesh">Anti-Infective Agents</api:keyword><api:keyword scheme="mesh">Bronchitis</api:keyword><api:keyword scheme="mesh">Ciprofloxacin</api:keyword><api:keyword scheme="mesh">Drug Therapy, Combination</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Prospective Studies</api:keyword><api:keyword scheme="mesh">Tablets</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>252</api:begin-page><api:end-page>261</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>S0954-6111(99)90021-5</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>7</api:day><api:month>10</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Clinical Trial</api:item><api:item>Comparative Study</api:item><api:item>Journal Article</api:item><api:item>Multicenter Study</api:item><api:item>Randomized Controlled Trial</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>93</api:text></api:field></api:native></api:record><api:record format="native" id="881832" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10464889" last-modified-when="2020-10-13T17:25:00.307+01:00"><api:citation-count>10</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>A multinational, multicentre, randomized, prospective, parallel-group study compared treatment with ciprofloxacin administered as an oral suspension (500 mg twice daily for 7 days) with co-amoxiclav tablets (625 mg three times daily for 7 days) in patients suffering from acute exacerbations of chronic bronchitis (AECB). A total of 147 of 165 cases treated with ciprofloxacin (89.1%) and 146 of 162 cases treated with co-amoxiclav (90.1%) were classified as being clinical successes at the primary efficacy assessment 7 days after the end of therapy (assessed as reduced cough, improvement in dyspnoea, reduction in 24-h sputum volume or reduced purulence of sputum). Treatment equivalence was statistically confirmed; treatment difference:--1.0%, 95% CI--6.6% and 4.5%. Before treatment, 128 bacterial strains were isolated from 103 patients (60 ciprofloxacin and 68 co-amoxiclav). The most commonly isolated organism was Haemophilus influenzae (60 isolates), followed by Moraxella catarrhalis (12 isolates), Streptococcus pneumoniae (11 isolates) and Staphylococcus aureus (10 isolates). At day 14, 40 of 46 ciprofloxacin-treated patients (87.0%) and 46 of 55 co-amoxiclav-treated patients (83.6%) who were valid for bacteriological analysis were classified as being bacteriological success (classed as eradication, eradication with colonization or presumed eradication; treatment difference: 3.3%, 95% CI--8.3% and 14.9%). The adverse event profile was comparable between treatment groups. Most adverse events considered possibly or probably related to study drug were related to the gastrointestinal system and were of mild or moderate severity: nausea (13% ciprofloxacin, 10.6% co-amoxiclav), flatulence (10.3% ciprofloxacin, 3.9% co-amoxiclav), abdominal pain (7.6% ciprofloxacin, 7.3% co-amoxiclav) and diarrhoea (4.3% ciprofloxacin, 6.7% co-amoxiclav). We concluded that a 7-day course of ciprofloxacin suspension is equivalent to a 7-day course of co-amoxiclav tablets in terms of clinical and bacteriological efficacy and tolerability for the treatment of AECB. Thus, ciprofloxacin suspension may offer a suitable alternative treatment for AECB patients who have difficulty in swallowing, or who prefer liquid medications to tablets.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Royal Hallamshire Hospital, Sheffield, U.K.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-4297-6728</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kuss</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Berrisoul</api:last-name><api:initials>F</api:initials><api:first-names>F</api:first-names><api:separate-first-names><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kearsley</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Torres</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kubin</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0954-6111(99)90021-5</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0954-6111(99)90021-5"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0954-6111(99)90021-5"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-3064</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10464889</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6111</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Respiratory medicine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Bronchitis</api:keyword><api:keyword scheme="mesh">Acute Disease</api:keyword><api:keyword scheme="mesh">Amoxicillin-Potassium Clavulanate Combination</api:keyword><api:keyword scheme="mesh">Ciprofloxacin</api:keyword><api:keyword scheme="mesh">Tablets</api:keyword><api:keyword scheme="mesh">Anti-Infective Agents</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword><api:keyword scheme="mesh">Drug Therapy, Combination</api:keyword><api:keyword scheme="mesh">Prospective Studies</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>252</api:begin-page><api:end-page>261</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>28</api:day><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Comparative Study</api:item><api:item>Clinical Trial</api:item><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Multicenter Study</api:item><api:item>Randomized Controlled Trial</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>93</api:text></api:field></api:native></api:record><api:record format="native" id="2921640" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1027286682" last-modified-when="2023-11-26T11:41:13.17+00:00"><api:citation-count>15</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Hallamshire Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01333750206.10</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kuss</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="DE"><api:line type="organisation">Westfalenstr. 24, 40472 Düsseldorf, Germany</api:line><api:line type="city">Duesseldorf</api:line><api:line type="state">North Rhine-Westphalia</api:line><api:line type="country">Germany</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Berrisoul</api:last-name><api:initials>F</api:initials><api:first-names>F</api:first-names><api:separate-first-names><api:first-name>F</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="FR"><api:line type="organisation">61 rue Balard, 75015, Paris, France</api:line><api:line type="city">Paris</api:line><api:line type="state">Ile-de-France</api:line><api:line type="country">France</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Kearsley</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Richmond Medical Centre, 462 Richmond Road, Sheffield, U.K.</api:line><api:line type="city">Sheffield</api:line><api:line type="state">England</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Torres</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="ES"><api:line type="organisation">Hospital Clínic de Barcelona</api:line><api:line type="city">Barcelona</api:line><api:line type="country">Spain</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.013605501140.89</api:identifier></api:identifiers></api:person><api:person><api:last-name>Kubin</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Bayer (United Kingdom)</api:line><api:line type="city">Newbury</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01245762252.19</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/s0954-6111(99)90021-5</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/s0954-6111(99)90021-5"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/s0954-6111(99)90021-5"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10464889</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6111</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Respiratory Medicine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Clinical Trials and Supportive Activities</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="rcdc">Digestive Diseases</api:keyword><api:keyword scheme="rcdc">Infectious Diseases</api:keyword><api:keyword scheme="hrcs-rac">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="mesh">Acute Disease</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Aged</api:keyword><api:keyword scheme="mesh">Aged, 80 and over</api:keyword><api:keyword scheme="mesh">Amoxicillin-Potassium Clavulanate Combination</api:keyword><api:keyword scheme="mesh">Anti-Infective Agents</api:keyword><api:keyword scheme="mesh">Bronchitis</api:keyword><api:keyword scheme="mesh">Ciprofloxacin</api:keyword><api:keyword scheme="mesh">Drug Therapy, Combination</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Prospective Studies</api:keyword><api:keyword scheme="mesh">Tablets</api:keyword><api:keyword scheme="mesh">Treatment Outcome</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Hybrid OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>252</api:begin-page><api:end-page>261</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Elsevier</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.41</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>93</api:text></api:field></api:native></api:record><api:record format="native" id="240034" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000079944100005" last-modified-when="2024-03-14T05:32:31.433+00:00"><api:citation-count>10</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kuss</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Berrisoul</api:last-name><api:initials>F</api:initials><api:first-names>F</api:first-names><api:separate-first-names><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kearsley</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Torres</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kubin</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000079944100005&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1016/S0954-6111(99)90021-5</api:text><api:links><api:link type="doi" href="http://doi.org/10.1016/S0954-6111(99)90021-5"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1016/S0954-6111(99)90021-5"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-3064</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">190CN</api:identifier><api:identifier scheme="pubmed">10464889</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6111</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>RESPIRATORY MEDICINE</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>252</api:begin-page><api:end-page>261</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>93</api:text></api:field></api:native></api:record><api:record format="native" id="22622" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000079944100005" last-modified-when="2014-07-25T11:03:23.06+01:00"><api:citation-count>10</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1878" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1878"/></api:links><api:last-name>Read</api:last-name><api:initials>RC</api:initials><api:first-names>RC</api:first-names><api:separate-first-names><api:first-name>R</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kuss</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Berrisoul</api:last-name><api:initials>F</api:initials><api:first-names>F</api:first-names><api:separate-first-names><api:first-name>F</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kearsley</api:last-name><api:initials>N</api:initials><api:first-names>N</api:first-names><api:separate-first-names><api:first-name>N</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Torres</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Kubin</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0954-6111</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>RESP MED</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>RESPIRATORY-TRACT INFECTIONS</api:keyword><api:keyword>ACUTE PURULENT EXACERBATIONS</api:keyword><api:keyword>CLAVULANIC ACID</api:keyword><api:keyword>AMOXICILLIN/CLAVULANIC ACID</api:keyword><api:keyword>ANTIMICROBIAL RESISTANCE</api:keyword><api:keyword>AMOXYCILLIN CLAVULANATE</api:keyword><api:keyword>HAEMOPHILUS-INFLUENZAE</api:keyword><api:keyword>PHARMACOKINETICS</api:keyword><api:keyword>PHARMACODYNAMICS</api:keyword><api:keyword>ANTIBIOTICS</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>252</api:begin-page><api:end-page>261</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>4</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>93</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Acute Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Amoxicillin-Potassium Clavulanate Combination</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Anti-Infective Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Bronchitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Ciprofloxacin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Drug Therapy, Combination</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Prospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tablets</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Treatment Outcome</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Bronchitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Acute Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Amoxicillin-Potassium Clavulanate Combination</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Ciprofloxacin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tablets</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Anti-Infective Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Treatment Outcome</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Drug Therapy, Combination</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Prospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Trials and Supportive Activities</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Digestive Diseases</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Infectious Diseases</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6 Evaluation of treatments and therapeutic interventions</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">6.1 Pharmaceuticals</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Acute Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Aged, 80 and over</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Amoxicillin-Potassium Clavulanate Combination</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Anti-Infective Agents</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Bronchitis</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Ciprofloxacin</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Drug Therapy, Combination</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Prospective Studies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tablets</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Treatment Outcome</api:keyword><api:keyword origin="record-data" source="wos">RESPIRATORY-TRACT INFECTIONS</api:keyword><api:keyword origin="record-data" source="wos">ACUTE PURULENT EXACERBATIONS</api:keyword><api:keyword origin="record-data" source="wos">CLAVULANIC ACID</api:keyword><api:keyword origin="record-data" source="wos">AMOXICILLIN/CLAVULANIC ACID</api:keyword><api:keyword origin="record-data" source="wos">ANTIMICROBIAL RESISTANCE</api:keyword><api:keyword origin="record-data" source="wos">AMOXYCILLIN CLAVULANATE</api:keyword><api:keyword origin="record-data" source="wos">HAEMOPHILUS-INFLUENZAE</api:keyword><api:keyword origin="record-data" source="wos">PHARMACOKINETICS</api:keyword><api:keyword origin="record-data" source="wos">PHARMACODYNAMICS</api:keyword><api:keyword origin="record-data" source="wos">ANTIBIOTICS</api:keyword><api:keyword scheme="for" origin="issn-inferred">1102 Cardiorespiratory Medicine and Haematology</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Respiratory System</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3201 Cardiovascular medicine and haematology</api:keyword></api:keywords></api:all-labels><api:journal issn="0954-6111" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974415" title="Respiratory Medicine"><api:records><api:record source-name="summary"><api:title>Respiratory Medicine</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/451/relationships"/></api:object></api:result></api:response>